Nutex Health (NASDAQ:NUTX) Stock Jumps 13.1% – Time to Buy?

Shares of Nutex Health Inc. (NASDAQ:NUTX) traded up 13.1% during mid-day trading on Wednesday. The company traded as high as $203.08 and last traded at $203.0450. 92,673 shares were traded during trading, a decline of 44% from the average daily volume of 166,780 shares. The stock had previously closed at $179.58.

Analyst Upgrades and Downgrades

NUTX has been the subject of several analyst reports. Lake Street Capital reissued a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Wall Street Zen cut Nutex Health from a “buy” rating to a “hold” rating in a research report on Saturday. LADENBURG THALM/SH SH started coverage on Nutex Health in a report on Monday, October 26th. They set a “buy” rating and a $336.00 price target for the company. B. Riley Financial reissued a “buy” rating on shares of Nutex Health in a research report on Friday, September 4th. Finally, Zacks Research lowered Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $323.67.

Nutex Health Stock Up 14.1%

The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The stock’s 50-day simple moving average is $203.08 and its 200-day simple moving average is $150.83. The firm has a market capitalization of $1.40 billion, a P/E ratio of 8.00 and a beta of 0.66.

Nutex Health (NASDAQ:NUTX) last announced its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. The firm had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. As a group, research analysts predict that Nutex Health Inc. will post 26.65 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Scott Saunders sold 203 shares of the firm’s stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the sale, the director directly owned 400 shares of the company’s stock, valued at $85,700. This trade represents a 33.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 44.68% of the company’s stock.

Hedge Funds Weigh In On Nutex Health

Institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of Nutex Health in the second quarter valued at approximately $69,612,000. Winmill & CO. Inc. bought a new position in Nutex Health in the 2nd quarter worth approximately $11,168,000. Empowered Funds LLC bought a new position in Nutex Health in the 2nd quarter worth approximately $7,720,000. Bank of New York Mellon Corp bought a new position in Nutex Health in the 2nd quarter worth approximately $3,956,000. Finally, Bridge City Capital LLC purchased a new position in Nutex Health in the 3rd quarter valued at approximately $3,918,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.